Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brian, if you still read this board, this is for you

Brian, if you still read this board, this is for you

posted on Jun 01, 2006 02:12PM
Brian, at the risk of repeating myself and offending those who grow weary of the same old text, FWIW, in my opinion, PTSC has much potential. But we will need a purposeful plan, executed in an orderly well thought out manner. It all hinges upon forthcoming licensing deals that we all are either expecting and/or are praying for. With these agreements, I believe we MUST have at least 10% reduction in shares outstanding, an organization structured to be Nasdaq acceptable, application made to be listed on Nasdaq, and plans for successive quarterly dividends. If the patents are as defendable as many believe, we have the potential to be valued at over $20 per share. The pieces are there for TPL and Pohl to assemble. As a spectator, I chew on my tums and pray for the best.
Share
New Message
Please login to post a reply